Last reviewed · How we verify

NCT05099042

Evaluating Quebec's Red-Cross Intervention

Completed NA Last updated 10 April 2024
What this trial tests

NA trial testing Recommendations and re-orientation towards appropriate physical, mental, and social health ressources in Social Isolation in 300 participants. Completed in 27 July 2022.

Timeline
28 June 2021
Primary endpoint
27 July 2022
27 July 2022

Quick facts

Lead sponsorCentre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment300
Start date28 June 2021
Primary completion27 July 2022
Estimated completion27 July 2022
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal

Who can join

65 and older, any sex, with Social Isolation or Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With the COVID-19 pandemic, elderly people (EP) living at home have seen their health deteriorated, thus increasing their needs in support and care. Indeed, while it was estimated that before the pandemic120 000 unattended living at home EP required care and services (taking bath, access to medication and food, etc.), the number doubled after COVID-19. Therefore, the waiting list for socio-medical services for unattended vulnerable clientele without a family doctor grew from 1300 to 1715 EP in a couple of months during the pandemic. With these numbers, it becomes clear that an intervention is needed. Truly, the Institut National d'Excellence en Santé et Services Sociaux (INESSS) concludes that it was pivotal to first identify the most vulnerable EP and second re-orient them according to their needs. Thus the principal investigator developed the Évaluation et orientation SOcio-GÉRiatrique (ESOGER) questionnaire available on a secure digital platform enabling both a rapid evaluation and intervention to asses EP needs and provide the adequate ressources. The principal investigator's previous research has demonstrated that ESOGER is one of the rare clinical tools of first contact in telehealth while being global, multidimensional, and equitable. Hence, the principal investigator hypothesizes that ESOGER is a clinical tool enabling first line care by the Red-Cross to vulnerable EP without a family doctor, which will lead to an improvement in their health, autonomy and quality of life. Moreover, the principal investigator also hypothesizes that for a better deployment, the tool needs to be adapted to Red-Cross' need and EP service providers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impacts of ESOGER home-based care and health services on spousal caregivers' anxiety, quality of life and burden: Findings from a pilot randomized controlled trial.
    Beauchet O, Normandin C, Mathieu P, Galéry K. · · 2026 · PMID 41385361 · DOI 10.1016/j.tjfa.2025.100114

Verify or expand the search:

Other recruiting trials for Social Isolation

Currently open trials in the same condition.

Other Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05099042.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing